Renso, R., Aroldi, A., Pioltelli, P., Gambacorti-Passerini, C., Elli, E. (2018). Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea. BLOOD CANCER JOURNAL, 8(6), 56 [10.1038/s41408-018-0091-6].
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
Aroldi, Andrea;Pioltelli, Pietro;Gambacorti-Passerini, Carlo;
2018
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
10281-216960.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Dimensione
297.19 kB
Formato
Adobe PDF
|
297.19 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
